Related Experiment Video
Updated: Sep 1, 2025

Author Spotlight: FISH as a Tool for Precise Gene Amplification Assessment in Cancer Specimens
Published on: July 12, 2024
Extrachromosomal DNA amplifications in cancer
Eunhee Yi1, Rocío Chamorro González2,3,4, Anton G Henssen5,6,7,8,9
1The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Abstract:
Extrachromosomal DNA (ecDNA) amplification is an important driver alteration in cancer. It has been observed in most cancer types and is associated with worse patient outcome. The functional impact of ecDNA has been linked to its unique properties, such as its circular structure that is associated with altered chromatinization and epigenetic regulatory landscape, as well as its ability to randomly segregate during cell division, which fuels intercellular copy number heterogeneity. Recent investigations suggest that ecDNA is structurally more complex than previously anticipated and that it localizes to specialized nuclear bodies (hubs) and can act in trans as an enhancer for genes on other ecDNAs or chromosomes. In this Review, we synthesize what is currently known about how ecDNA is generated and how its genetic and epigenetic architecture affects proto-oncogene deregulation in cancer. We discuss how recently identified ecDNA functions may impact oncogenesis but also serve as new therapeutic vulnerabilities in cancer.
Insights
Extrachromosomal DNA (ecDNA) amplification drives cancer by altering gene expression and promoting cell diversity. Understanding ecDNA
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Extrachromosomal DNA (ecDNA) amplification is a frequent driver of cancer, linked to poor patient prognosis.
- ecDNA's circular structure influences chromatin, epigenetics, and heterogeneous copy number during cell division.
Purpose of the Study:
- To review the generation of ecDNA.
- To explore the genetic and epigenetic architecture of ecDNA.
- To discuss ecDNA's role in proto-oncogene deregulation and its therapeutic potential.
Main Methods:
- Literature review and synthesis of current research on ecDNA.
- Analysis of ecDNA's structural complexity, localization, and functional mechanisms.
- Examination of ecDNA's impact on oncogenesis and potential as therapeutic targets.
Main Results:
- ecDNA exhibits complex structures, localizes to nuclear hubs, and can function as an enhancer.
- ecDNA's unique properties contribute to proto-oncogene amplification and deregulation.
- Recent findings highlight ecDNA's role in driving cancer and its potential as a therapeutic vulnerability.
Conclusions:
- ecDNA generation and architecture are critical in cancer development.
- Targeting ecDNA's unique functions presents novel therapeutic opportunities in oncology.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Epigenetic Regulation
X-chromosome...
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation
Non-LTR Retrotransposons

